ZNF643 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.336400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.345600E-01
Normal-vs-Stage2
4.640000E-02
Normal-vs-Stage3
1.399560E-01
Normal-vs-Stage4
7.954800E-01
Stage1-vs-Stage2
3.513600E-01
Stage1-vs-Stage3
5.281600E-02
Stage1-vs-Stage4
5.318400E-01
Stage2-vs-Stage3
3.791200E-04
Stage2-vs-Stage4
8.632300E-02
Stage3-vs-Stage4
1.305000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.656400E-02
Normal-vs-AfricanAmerican
4.679400E-01
Normal-vs-Asian
8.822300E-03
Caucasian-vs-AfricanAmerican
2.433400E-01
Caucasian-vs-Asian
1.290800E-01
AfricanAmerican-vs-Asian
5.312300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.191500E-02
Normal-vs-Female
8.585800E-02
Male-vs-Female
2.478400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.343000E-01
Normal-vs-Age(41-60Yrs)
1.198440E-01
Normal-vs-Age(61-80Yrs)
4.662100E-02
Normal-vs-Age(81-100Yrs)
1.674300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.753000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.716000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.985000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.013010E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.904560E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.942800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.455700E-03
Normal-vs-Daily Drinker
1.595630E-01
Normal-vs-Weekly Drinker
1.769980E-01
Normal-vs-Occasional Drinker
2.010200E-01
Normal-vs-Social Drinker
3.158200E-01
Non Drinker-vs-Daily Drinker
3.450000E-01
Non Drinker-vs-Weekly Drinker
2.414000E-01
Non Drinker-vs-Occasional Drinker
9.791900E-02
Non Drinker-vs-Social Drinker
4.726400E-02
Daily Drinker-vs-Weekly Drinker
9.731800E-02
Daily Drinker-vs-Occasional Drinker
2.846000E-02
Daily Drinker-vs-Social Drinker
1.482110E-02
Weekly Drinker-vs-Occasional Drinker
7.976400E-01
Weekly Drinker-vs-Social Drinker
5.107800E-01
Occasional Drinker-vs-Social Drinker
6.543400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.236000E-01
Normal-vs-Grade 2
9.823600E-01
Normal-vs-Grade 3
9.916800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.158200E-01
Grade 1-vs-Grade 3
3.138400E-01
Grade 1-vs-Grade 4
9.236000E-01
Grade 2-vs-Grade 3
6.785600E-01
Grade 2-vs-Grade 4
9.823600E-01
Grade 3-vs-Grade 4
9.916800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.322000E-02
Normal-vs-NonDiabetic
2.396000E-02
Diabetic-vs-NonDiabetic
2.247200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.902950E-01
Normal-vs-NoPancreatitis
4.723900E-02
Pancreatitis-vs-NoPancreatitis
1.530790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.704200E-02
Normal-vs-N1
5.426400E-02
N0-vs-N1
8.635800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.634610E-01
Normal-vs-TP53-NonMutant
2.507400E-01
TP53-Mutant-vs-TP53-NonMutant
6.276400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
